JP2021525752A5 - - Google Patents

Info

Publication number
JP2021525752A5
JP2021525752A5 JP2020566834A JP2020566834A JP2021525752A5 JP 2021525752 A5 JP2021525752 A5 JP 2021525752A5 JP 2020566834 A JP2020566834 A JP 2020566834A JP 2020566834 A JP2020566834 A JP 2020566834A JP 2021525752 A5 JP2021525752 A5 JP 2021525752A5
Authority
JP
Japan
Prior art keywords
present
activation
novel heterocyclic
stat3 protein
suppresses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020566834A
Other languages
English (en)
Japanese (ja)
Other versions
JP7558066B2 (ja
JP2021525752A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2019/006554 external-priority patent/WO2019231271A1/en
Publication of JP2021525752A publication Critical patent/JP2021525752A/ja
Publication of JP2021525752A5 publication Critical patent/JP2021525752A5/ja
Application granted granted Critical
Publication of JP7558066B2 publication Critical patent/JP7558066B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020566834A 2018-05-31 2019-05-31 複素環誘導体及びその使用 Active JP7558066B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20180062450 2018-05-31
KR10-2018-0062450 2018-05-31
PCT/KR2019/006554 WO2019231271A1 (en) 2018-05-31 2019-05-31 Heterocyclic derivatives and use thereof

Publications (3)

Publication Number Publication Date
JP2021525752A JP2021525752A (ja) 2021-09-27
JP2021525752A5 true JP2021525752A5 (enExample) 2022-03-31
JP7558066B2 JP7558066B2 (ja) 2024-09-30

Family

ID=68698337

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020566834A Active JP7558066B2 (ja) 2018-05-31 2019-05-31 複素環誘導体及びその使用

Country Status (8)

Country Link
US (1) US12404249B2 (enExample)
EP (1) EP3802495B1 (enExample)
JP (1) JP7558066B2 (enExample)
KR (1) KR102229471B1 (enExample)
CN (1) CN112204010B (enExample)
ES (1) ES3041067T3 (enExample)
TW (1) TWI853814B (enExample)
WO (1) WO2019231271A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110105237B (zh) * 2019-06-06 2021-12-24 东北师范大学 一种β-偕二氟叠氮化合物及其制备和应用
WO2022187411A1 (en) * 2021-03-02 2022-09-09 Kumquat Biosciences Inc. Heterocycles and uses thereof
CN113845476B (zh) * 2021-11-08 2024-04-30 中国药科大学 一种喹诺酮衍生物及其制备方法和用途
CN114315802B (zh) * 2021-12-14 2023-06-16 西安医学院 一种喹唑啉含氮杂环衍生物及制备方法和用途
CA3246750A1 (en) 2022-04-20 2023-10-26 Kumquat Biosciences Inc. MACROCYCLES AND HETEROCYCLES AND THEIR USES
EP4296674A1 (en) 2022-06-20 2023-12-27 Université Toulouse III - Paul Sabatier Innovative molecules decreasing virulence of mycobacterium for the treatment of tuberculosis

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960007566A (ko) * 1994-08-19 1996-03-22 김정규 신규한 퀴놀릴아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도
AU4878601A (en) 2000-04-20 2001-11-07 Mitsubishi Corporation Aromatic amide compounds
PE20030008A1 (es) * 2001-06-19 2003-01-22 Bristol Myers Squibb Co Inhibidores duales de pde 7 y pde 4
WO2005061516A1 (en) * 2003-12-04 2005-07-07 Smithkline Beecham Corporation Novel chemical compounds
GB0420719D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
US20060074105A1 (en) * 2004-09-20 2006-04-06 Serenex, Inc. Substituted quinoline and quinazoline inhibitors of quinone reductase 2
US7932257B2 (en) 2005-07-22 2011-04-26 Sunesis Pharmaceuticals, Inc. Substituted pyrazolo[4,3-d]pyrimidines as aurora kinase inhibitors
US20090170847A1 (en) * 2006-01-23 2009-07-02 Seung Chul Lee Imidazopyridine Derivatives Inhibiting Protein Kinase Activity, Method for the Preparation Thereof and Pharmaceutical Composition Containing Same
US20090004185A1 (en) * 2007-01-11 2009-01-01 Wyeth Amino-substituted quinazoline derivatives as inhibitors of beta-catenin/tcf-4 pathway and cancer treatment agents
EP2014663A1 (de) * 2007-07-12 2009-01-14 Bayer Schering Pharma AG Thienopyrimidylamine als Modulatoren des EP2-Rezeptors
DE102007032739A1 (de) 2007-07-13 2009-01-15 Merck Patent Gmbh Chinazolinamidderivate
AU2009219376B2 (en) * 2008-02-28 2014-09-25 Merck Patent Gmbh Protein kinase inhibitors and use thereof
US8466290B2 (en) 2008-07-10 2013-06-18 Pharma Ip General Incorporated Association STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient
JP5507567B2 (ja) 2008-09-26 2014-05-28 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ccr1受容体拮抗薬としてのアザインダゾール化合物
EP2331530B8 (en) * 2008-09-26 2013-12-25 National Health Research Institutes Fused multicyclic compounds as protein kinase inhibitors
BRPI1008325A2 (pt) * 2009-02-11 2020-08-25 Merck Patent Gmbh carboxamidas azaeterocíclicas de amino
WO2012079079A1 (en) * 2010-12-10 2012-06-14 President And Fellows Of Harvard College Production of induced pluripotent stem cells
WO2014145512A2 (en) * 2013-03-15 2014-09-18 President And Fellows Of Harvard College Potent small molecule inhibitors of autophagy, and methods of use thereof
KR20200047627A (ko) * 2017-08-31 2020-05-07 애브비 인코포레이티드 엑토뉴클레오티드 피로포스파타아제-포스포디에스테라아제 1(enpp-1) 저해제 및 그의 용도

Similar Documents

Publication Publication Date Title
CY1124084T1 (el) Αμιδο-υποκατεστημενα παραγωγα πυριδινυλοτριαζολης και χρησεις αυτων
JOP20210001B1 (ar) مشتقات 3-(5- هيدروكسي -1- أوكسو أيزو إندولين -2- يل) بيبريدين -2، 6- دايون واستخدامها لمعالجة أمراض مرتبطة ببروتين ذات أصبع الزنك من عائلة (ikaros 2 (ikzf2
PH12020551205A1 (en) Fap inhibitors
GEAP202215671A (en) Microbiocidal thiazole derivatives
IL280358A (en) Novel autotac chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprosing the same
EA201791261A1 (ru) 1,3-тиазол-2-ил замещенные бензамиды
MX2019012445A (es) Anticuerpos anti-peptido beta amiloide n3pglu y usos de los mismos.
CL2004001011A1 (es) Compuestos azabiciclicos derivados de n-arilsulfonilpiperidinas; inhibidores de la deposicion de la proteina beta amiloide; composicion farmaceutica; y su uso para el tratamiento del alzheimer y enfermedades neurodegenerativas.
EA202191991A1 (ru) Новые производные гетеротрициклического соединения и их применение
EA201792421A1 (ru) Амидозамещенные производные циклогексана
EA201691242A1 (ru) Фармацевтические композиции, содержащие azd9291
EA202190356A1 (ru) Композиции и способы лечения расстройств, ослабляемых активацией мускариновых рецепторов
MX379558B (es) Nueva forma cristalina de n-[5-(3,5-difluoro-bencilo)-1h-indazol-3-il]-4-(4-metilo-piperazina-1-il)-2-(tetrahidro-pirano-4-ilamino)-benzamida.
BR112018006866A2 (pt) compostos agonistas de ppar, composições farmacêuticas e métodos de uso dos mesmos
ME01456B (me) Fumaratna so (alfa s, beta r)-6-bromo-alfa-[2-(dimetilamino)etil]-2-metoksi-alfa-1-naftalenil-beta-fenil-3-kinolinetanola
SA521422467B1 (ar) مركبات هالو-آلِّيلامين واستخدامها
JP2018186833A5 (enExample)
JOP20210034A1 (ar) مركبات عطرية غير متجانسة كمثبطات Vanin
EA202191478A1 (ru) Гетероароматические соединения в качестве ингибиторов ванина
EA202192925A1 (ru) Твердые формы ингибитора glyt1
SG11202011427XA (en) Fish protein hydrolysate powder and a composition comprising said powder for use as a medicament
SG10201805646WA (en) Angiopoietin-like 4 antibodies and methods of use
BR112021011368A2 (pt) Cocristal de cetoprofeno, composições compreendendo o mesmo, processo para a sua produção e usos dos mesmos
HUE066894T2 (hu) Triszamid vegyületek és azokat tartalmazó készítmények
EP3880671A4 (en) NOVEL COMPOUND AS A PROTEIN KINAS INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREOF